Medical News

RSS

Sinapis Pharma completes Bridge financing to continue support drug development program

Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program. Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology. The company has strong pre-clinical data in stroke and traumatic brain injury animal models conclusively demonstrating a 12-hour therapeutic window and multiple pathway neuroprotection.

24 May 2010

Repligen's RG2833 granted orphan drug designation for treatment of Friedreich's ataxia

Repligen Corporation announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation to RG2833, a selective histone deacetylase 3 inhibitor for the treatment of Friedreich's ataxia. Orphan drug designation qualifies Repligen to receive seven years of marketing exclusivity in the United States if the company is the first to obtain marketing approval for RG2833 for the treatment of Friedreich's ataxia.

24 May 2010

Hospitals facing new payment squeezes

News outlets report on payment issues for hospitals, including those stemming from the new health law.

24 May 2010

2010 Southeast Michigan Mid-Market Group Benefits Survey released

McGraw Wentworth, Michigan's largest employee group benefit brokerage/consulting firm, today released the results of its 2010 Southeast Michigan Mid-Market Group Benefits Survey. The annual survey, now in its seventh year, tracks health benefits and trends for 2010 among 414 southeast Michigan organizations with 100-10,000 employees.

24 May 2010

FDA clears Simplexa Influenza A H1N1 (2009) test

The U.S. Food and Drug Administration today announced it has cleared the Simplexa Influenza A H1N1 (2009), a test for the 2009 H1N1 Influenza Virus in patients with signs and symptoms of respiratory infection.

24 May 2010

Today's OpEds: Taxing health plans, a health care 'loophole,' NY Times on medical loss ratio

Few Americans know what a "medical loss ratio" is, but a fierce struggle over how to calculate it under the new health care reform law will determine how much insurers must spend on patient care and how much they can retain for administration and profits. This is but one of many battles that will emerge as federal and state regulators develop regulations to implement reform (5/23).

24 May 2010

Dialog Medical becomes newest Affinity Program Partner of AUA

Dialog Medical, the leading provider of informed consent and patient education systems for physician practices and hospitals, today announced that it has become the newest Affinity Program Partner of the American Urological Association.

24 May 2010

BinaxNOW PBP2a test to detect PBP2a in MRSA

AdvanDx today announced that it will offer the BinaxNOW PBP2a test from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the United States. The test provides rapid detection of the penicillin-binding protein 2a present in Methicillin-Resistant Staphylococcus aureus (MRSA) directly from S. aureus positive blood cultures.

24 May 2010

Lawmakers could vote this week on three-year 'doc fix,' COBRA subsidy extension

Before they leave for the Memorial Day recess, lawmakers face legislation which includes a provision on Medicare payments to physicians and an extension of the COBRA subsidy to newly laid-off workers.

24 May 2010

66% of patients with schizophrenia have extreme trust in their psychiatrists: New survey

According to a new survey sponsored by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 80 percent of patients with schizophrenia, a chronic, severe and disabling brain disorder, say their psychiatrists do well or very well in treating them with courtesy and respect. This positive relationship is particularly important in treating schizophrenia as patients and psychiatrists must work closely together to determine appropriate treatment plans that will help patients manage their symptoms and reduce their risk of relapse.

24 May 2010

Thymosin beta 4 reduces brain tissue damage, improves brain function in rats: Research paper

RegeneRx Biopharmaceuticals, Inc. announced today that in a preclinical research paper published in the May 2010 issue of the Journal of Neurosurgery, (online ahead of publication), scientists found that the systemic administration of thymosin beta 4, or Tβ4, significantly reduced brain tissue damage and improved brain function in rats with traumatic brain injury, or TBI.

24 May 2010

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today announced the availability of the OnePath Gaucher Application. The first and only application developed specifically for patients in the U.S. with Type 1 Gaucher disease, it is free and ready for download at the iTunes Application store.

24 May 2010

Study: Health law could mean penalties for one in three employers

News outlets covered analyses of health law provisions affecting businesses. "About one-third of employers subject to major requirements of the new health care law may face tax penalties because they offer health insurance that could be considered unaffordable to some employees, a new study says," The New York Times reports.

24 May 2010

Pro-Pharmaceuticals plans to submit Phase III trial design for DAVANAT to FDA

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.

24 May 2010

NormOxys raises $17.5M in Series B financing round

NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.

24 May 2010

Zotec Partners announces strategic technology alliance with Florida-based MBS

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems software and services, is announcing today a strategic technology alliance with Florida-based Medical Business Service, Inc. This alliance enables Zotec Partners to further penetrate the radiology and pathology markets and strengthen its position as a leader in hospital-based revenue cycle management.

24 May 2010

Immunome announces completion of financing by BioAdvance

Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, announced today the completion of a financing by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. The funding round also included private investors.

24 May 2010

Expression Analysis agrees to purchase PacBio RS DNA sequencing system from Pacific Biosciences

Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.

24 May 2010

Dole Nutrition Handbook recognized with prestigious Living Now Book Award

Dole Food Company, Inc. is pleased to have received the prestigious Living Now Book Award for the Dole Nutrition Handbook: What You Need to Eat And How To Live For A Longer Healthier Life. The gold medal award is the top honor in the competition's Nutrition & Diet category. On Earth Day each year, the Jenkins Group - an organization dedicated to promoting books that enrich readers' lives in Earth friendly ways - presents the Living Now Book Awards to honor "books for better living."

24 May 2010

China Yongxin Pharmaceuticals first-quarter 2010 revenues increase 16.3% to $10.68M

China Yongxin Pharmaceuticals Inc., one of the leading health products distribution and retail sales companies in China, today announced its financial results for the first quarter ending March 31, 2010.

24 May 2010

Medical News

Sinapis Pharma completes Bridge financing to continue support drug development program

Repligen's RG2833 granted orphan drug designation for treatment of Friedreich's ataxia

Hospitals facing new payment squeezes

2010 Southeast Michigan Mid-Market Group Benefits Survey released

FDA clears Simplexa Influenza A H1N1 (2009) test

Today's OpEds: Taxing health plans, a health care 'loophole,' NY Times on medical loss ratio

Dialog Medical becomes newest Affinity Program Partner of AUA

BinaxNOW PBP2a test to detect PBP2a in MRSA

Lawmakers could vote this week on three-year 'doc fix,' COBRA subsidy extension

66% of patients with schizophrenia have extreme trust in their psychiatrists: New survey

Thymosin beta 4 reduces brain tissue damage, improves brain function in rats: Research paper

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

Study: Health law could mean penalties for one in three employers

Pro-Pharmaceuticals plans to submit Phase III trial design for DAVANAT to FDA

NormOxys raises $17.5M in Series B financing round

Zotec Partners announces strategic technology alliance with Florida-based MBS

Immunome announces completion of financing by BioAdvance

Expression Analysis agrees to purchase PacBio RS DNA sequencing system from Pacific Biosciences

Dole Nutrition Handbook recognized with prestigious Living Now Book Award

China Yongxin Pharmaceuticals first-quarter 2010 revenues increase 16.3% to $10.68M

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News